Locus Pharmaceuticals, a drug company that has developed its own internal and partnered pipeline, focusing on oncology, immunology, and inflammatory targets, has rebranded as Ansaris. Ansaris was formed in 2009 to leverage the strengths and fully realize the value of Locus' drug discovery computational platform and 10 years' experience in integrated drug design, discovery, and development of novel targets. Ansaris establishes collaborations and partnerships with companies seeking innovative solutions to drug design challenges.

To go directly to www.ansarisbio.com, click here.

.